SCHEMBL7758402

SCHEMBL7758402

NC(=NC1CCCCC1)N(C1CCCCC1)C1CCNCC1

nearest known ligand 0.37

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.37
SLC6A4 P31645 7/20 0.35
SLC6A2 P23975 6/20 0.35
SLC6A3 Q01959 4/20 0.35
KCNH2 Q12809 2/20 0.35
PHGDH O43175 1/20 0.32
KDM4E B2RXH2 1/20 0.32
NOS2 P35228 1/20 0.31
EPHX1 P07099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34985 0.92 SLC6A2 (0.43) SIGMAR1SLC6A4SLC6A2SLC6A3KCNH2
SCHEMBL3295732 0.89 SIGMAR1 (0.44) SIGMAR1PHGDHKDM4EEPHX1
SCHEMBL3295724 0.89 SIGMAR1 (0.44) SIGMAR1PHGDHKDM4EEPHX1
SCHEMBL3911153 0.87 SIGMAR1 (0.41) SIGMAR1PHGDHKDM4E
SCHEMBL35554 0.85 SLC6A2 (0.38) SIGMAR1SLC6A4SLC6A2SLC6A3KCNH2
Bicarbonate SCHEMBL9555184 0.82 SIGMAR1 (0.39) SIGMAR1PHGDHKDM4EEPHX1
Bicarbonate SCHEMBL9555194 0.82 SIGMAR1 (0.39) SIGMAR1PHGDHKDM4EEPHX1
Trichloroacetic Acid SCHEMBL9636965 0.79 SIGMAR1 (0.34) SIGMAR1PHGDHKDM4E
Trichloroacetic Acid SCHEMBL9636957 0.79 SIGMAR1 (0.34) SIGMAR1PHGDHKDM4E
SCHEMBL27624686 0.74 SLC6A4 (0.42) SLC6A4SLC6A2SLC6A3KCNH2PHGDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1086088-A2 NOVEL NEUROKININ ANTAGONISTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS Boehringer Ingelheim Pharma KG (DE) 2001-03-28 EP disclosed
WO-1999062893-A2 NOVEL NEUROKININ ANTAGONISTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-12-09 WO disclosed